Despite those considerable divergences between TISF and tumor tissue, for some key genes, on the other hand, high concordance was observed between TISF and tumor tissue, one is the above-mentioned IDH1, another example is the PTEN mutation (three patients, 100%) which can activate the PI3K/AKT/mTOR signaling pathways (18). This evidence concerns the gene MTOR and neoplasm.